These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
86 related items for PubMed ID: 9293452
1. Humoral coagulation and early complications after allogeneic bone marrow transplantation. Nürnberger W, Kruck H, Mauz-Körholz C, Burdach S, Göbel U. Klin Padiatr; 1997; 209(4):209-15. PubMed ID: 9293452 [Abstract] [Full Text] [Related]
2. Phase II trial of heparin prophylaxis for veno-occlusive disease of the liver in children undergoing bone marrow transplantation. Rosenthal J, Sender L, Secola R, Killen R, Millerick M, Murphy L, Cairo MS. Bone Marrow Transplant; 1996 Jul; 18(1):185-91. PubMed ID: 8832013 [Abstract] [Full Text] [Related]
3. Hypercoagulability in patients undergoing autologous or allogeneic BMT for hematological malignancies. Catani L, Gugliotta L, Mattioli Belmonte M, Vianelli N, Gherlinzoni F, Miggiano MC, Belardinelli AR, Rosti G, Calori E, Bandini G. Bone Marrow Transplant; 1993 Sep; 12(3):253-9. PubMed ID: 8241985 [Abstract] [Full Text] [Related]
4. Relevance of proteins C and S, antithrombin III, von Willebrand factor, and factor VIII for the development of hepatic veno-occlusive disease in patients undergoing allogeneic bone marrow transplantation: a prospective study. Lee JH, Lee KH, Kim S, Lee JS, Kim WK, Park CJ, Chi HS, Kim SH. Bone Marrow Transplant; 1998 Nov; 22(9):883-8. PubMed ID: 9827816 [Abstract] [Full Text] [Related]
8. Veno-occlusive disease of the liver after allogeneic bone marrow transplantation in children with hematologic malignancies: incidence, onset time and risk factors. Hasegawa S, Horibe K, Kawabe T, Kato K, Kojima S, Matsuyama T, Hirabayashi N. Bone Marrow Transplant; 1998 Dec; 22(12):1191-7. PubMed ID: 9894723 [Abstract] [Full Text] [Related]
11. Early hemostatic alterations following bone marrow transplantation: a prospective study. Vannucchi AM, Rafanelli D, Longo G, Bosi A, Guidi S, Saccardi R, Filimberti E, Cinotti S, Grossi A, Morfini M. Haematologica; 1994 Dec; 79(6):519-25. PubMed ID: 7896209 [Abstract] [Full Text] [Related]
14. [Intracranial hemorrhage and hemostasis. Monitoring patients after intracranial hemorrhage by determination and follow-up of activation products of blood coagulation]. Menges T, von Lessen A, Welters I, Wagner RM, Ruwoldt R, Boldt J, Hempelmann G. Infusionsther Transfusionsmed; 1994 Aug; 21(4):244-50. PubMed ID: 7950289 [Abstract] [Full Text] [Related]
15. Laboratory markers of veno-occlusive disease in the course of bone marrow and subsequent liver transplantation. Salat C, Holler E, Wolf C, Kolb HJ, Reinhardt B, Pihusch R, Krämling HJ, Heinemann V, Haller M, Hiller E. Bone Marrow Transplant; 1997 Mar; 19(5):487-90. PubMed ID: 9052916 [Abstract] [Full Text] [Related]
16. Reactivation of coagulation after stopping infusions of recombinant hirudin and unfractionated heparin in unstable angina and myocardial infarction without ST elevation: results of a randomized trial. OASIS Pilot Study Investigators. Organization to Assess Strategies for Ischemic++ Syndromes. Flather MD, Weitz JI, Yusuf S, Pogue J, Sussex B, Campeau J, Gill J, Schuld R, Joyner CD, Morris AL, Lai C, Théroux P, Marquis JF, Chan YK, Venkatesh G, Jessel A. Eur Heart J; 2000 Sep; 21(17):1473-81. PubMed ID: 10952840 [Abstract] [Full Text] [Related]